Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 4
1952 2
1953 1
1954 6
1955 12
1956 6
1957 3
1958 23
1959 13
1960 9
1961 14
1962 16
1963 24
1964 18
1965 28
1966 33
1967 32
1968 35
1969 42
1970 43
1971 61
1972 50
1973 49
1974 48
1975 48
1976 48
1977 71
1978 59
1979 77
1980 75
1981 67
1982 89
1983 78
1984 81
1985 78
1986 105
1987 110
1988 123
1989 134
1990 121
1991 121
1992 142
1993 133
1994 124
1995 119
1996 131
1997 171
1998 159
1999 173
2000 227
2001 238
2002 213
2003 257
2004 270
2005 294
2006 294
2007 314
2008 319
2009 371
2010 383
2011 439
2012 440
2013 459
2014 423
2015 455
2016 453
2017 453
2018 474
2019 462
2020 514
2021 542
2022 566
2023 569
2024 457
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,889 results

Results by year

Filters applied: . Clear all
Page 1
ISPD Catheter-Related Infection Recommendations: 2017 Update.
Szeto CC, Li PK, Johnson DW, Bernardini J, Dong J, Figueiredo AE, Ito Y, Kazancioglu R, Moraes T, Van Esch S, Brown EA. Szeto CC, et al. Among authors: ito y. Perit Dial Int. 2017 Mar-Apr;37(2):141-154. doi: 10.3747/pdi.2016.00120. Perit Dial Int. 2017. PMID: 28360365 Review. No abstract available.
Variation in Peritoneal Dialysis-Related Peritonitis Outcomes in the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS).
Al Sahlawi M, Zhao J, McCullough K, Fuller DS, Boudville N, Ito Y, Kanjanabuch T, Nessim SJ, Piraino BM, Pisoni RL, Teitelbaum I, Woodrow G, Kawanishi H, Johnson DW, Perl J. Al Sahlawi M, et al. Among authors: ito y. Am J Kidney Dis. 2022 Jan;79(1):45-55.e1. doi: 10.1053/j.ajkd.2021.03.022. Epub 2021 May 28. Am J Kidney Dis. 2022. PMID: 34052357
Reply.
Fujita A, Kataoka K, Takeuchi J, Nakano Y, Horiguchi E, Kaneko H, Ito Y, Terasaki H. Fujita A, et al. Among authors: ito y. Retina. 2021 Sep 1;41(9):e54. doi: 10.1097/IAE.0000000000003173. Retina. 2021. PMID: 33814538 No abstract available.
A risk-based subgroup analysis of the effect of adjuvant S-1 in estrogen receptor-positive, HER2-negative early breast cancer.
Takada M, Imoto S, Ishida T, Ito Y, Iwata H, Masuda N, Mukai H, Saji S, Ikeda T, Haga H, Saeki T, Aogi K, Sugie T, Ueno T, Ohno S, Ishiguro H, Kanbayashi C, Miyamoto T, Hagiwara Y, Toi M. Takada M, et al. Among authors: ito y. Breast Cancer Res Treat. 2023 Dec;202(3):485-496. doi: 10.1007/s10549-023-07099-4. Epub 2023 Sep 7. Breast Cancer Res Treat. 2023. PMID: 37676450 Free PMC article.
Efficient detection of somatic UBA1 variants and clinical scoring system predicting patients with variants in VEXAS syndrome.
Maeda A, Tsuchida N, Uchiyama Y, Horita N, Kobayashi S, Kishimoto M, Kobayashi D, Matsumoto H, Asano T, Migita K, Kato A, Mori I, Morita H, Matsubara A, Marumo Y, Ito Y, Machiyama T, Shirai T, Ishii T, Kishibe M, Yoshida Y, Hirata S, Akao S, Higuchi A, Rokutanda R, Nagahata K, Takahashi H, Katsuo K, Ohtani T, Fujiwara H, Nagano H, Hosokawa T, Ito T, Haji Y, Yamaguchi H, Hagino N, Shimizu T, Koga T, Kawakami A, Kageyama G, Kobayashi H, Aoki A, Mizokami A, Takeuchi Y, Motohashi R, Hagiyama H, Itagane M, Teruya H, Kato T, Miyoshi Y, Kise T, Yokogawa N, Ishida T, Umeda N, Isogai S, Naniwa T, Yamabe T, Uchino K, Kanasugi J, Takami A, Kondo Y, Furuhashi K, Saito K, Ohno S, Kishimoto D, Yamamoto M, Fujita Y, Fujieda Y, Araki S, Tsushima H, Misawa K, Katagiri A, Kobayashi T, Hashimoto K, Sone T, Hidaka Y, Ida H, Nishikomori R, Doi H, Fujimaki K, Akasaka K, Amano M, Matsushima H, Kashino K, Ohnishi H, Miwa Y, Takahashi N, Takase-Minegishi K, Yoshimi R, Kirino Y, Nakajima H, Matsumoto N. Maeda A, et al. Among authors: ito y. Rheumatology (Oxford). 2024 Aug 1;63(8):2056-2064. doi: 10.1093/rheumatology/kead425. Rheumatology (Oxford). 2024. PMID: 37606963
IL-1 as a target in inflammation.
Ito Y, Kaneko N, Iwasaki T, Morikawa S, Kaneko K, Masumoto J. Ito Y, et al. Endocr Metab Immune Disord Drug Targets. 2015;15(3):206-11. Endocr Metab Immune Disord Drug Targets. 2015. PMID: 26333726 Review.
Multifocal "CEOT": Possible "MCHDF"?
Ide F, Ito Y, Muramatsu T, Kikuchi K. Ide F, et al. Among authors: ito y. J Oral Maxillofac Surg. 2022 Feb;80(2):206-207. doi: 10.1016/j.joms.2021.07.033. Epub 2021 Oct 14. J Oral Maxillofac Surg. 2022. PMID: 34656511 No abstract available.
Charcot-Leyden crystals in kidney.
Hayashi S, Sugiura T, Hakamata S, Hattori S, Murakami Y, Hasegawa R, Matsushima H, Ito Y, Ueki S. Hayashi S, et al. Among authors: ito y. Kidney Int. 2023 Jul;104(1):206. doi: 10.1016/j.kint.2023.02.007. Kidney Int. 2023. PMID: 37349054 No abstract available.
11,889 results
You have reached the last available page of results. Please see the User Guide for more information.